skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

106 studies were found about Specific Populations, Female Only

A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir/Ritonavir, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women

Condition: HIV; HIV Infections; Pregnancy

NCT ID: NCT00855335

Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women

Condition: Hazardous Alcohol Use; Binge Drinking; High Risk Sexual Behaviors; HIV Risk Reduction; HIV Infection

NCT ID: NCT01125371

Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel

Condition: HIV Infections

NCT ID: NCT00197366

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?

Condition: HIV/AIDS

NCT ID: NCT02070900

Comparison of Two IUDs Among Cape Town HIV-positive Women: A Randomized Controlled Trial Assessing Safety of Registered Products in South Africa

Condition: HIV

NCT ID: NCT01721798

Trial of SAVVY Vaginal Gel and HIV in Nigeria

Condition: HIV Infections

NCT ID: NCT00130078

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Condition: HIV; Pregnancy

NCT ID: NCT01854762

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Condition: HIV Infections

NCT ID: NCT01539226

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women

Condition: HIV Infections

NCT ID: NCT01617096

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

Condition: HIV Infections

NCT ID: NCT01511237

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir

Condition: HIV Infection; Osteopenia

NCT ID: NCT01902186

Clinical Trial to Reduce Drinking in Women With HIV

Condition: HIV Infection

NCT ID: NCT01625091

Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT01157442

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00825929

Study to Improve Survival Among HIV-Exposed Infants in Botswana

Condition: HIV Infections; Neutropenia; Anemia

NCT ID: NCT01229761

Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions

Condition: Dating Violence; HIV Infections

NCT ID: NCT01326195

Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

Condition: HIV-1 Infection

NCT ID: NCT01701895

Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir

Condition: HIV Infections

NCT ID: NCT02097108

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.

Condition: 1- Women; 2- HIV Infection; 3- Followed in West Indies and French Guiana for His Infection; 4- Acceptance of the Use of Nadis® Medical Files

NCT ID: NCT01226368

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

Condition: Anal Cancer; HIV Infection; Human Papilloma Virus Infection

NCT ID: NCT01946139

Women's Interagency HIV Study (WIHS)

Condition: HIV Infections

NCT ID: NCT00000797

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Condition: HIV Prevention

NCT ID: NCT01386294

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Condition: HIV Infections

NCT ID: NCT00514098

HIV and Drug Use in Georgian Women

Condition: Human Immunodeficiency Virus

NCT ID: NCT01331460

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

Condition: Malaria in Pregnancy; HIV Infection

NCT ID: NCT01746199

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study

Condition: Hiv Infection

NCT ID: NCT01952587

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01910402

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries

Condition: HIV

NCT ID: NCT00341302

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

Condition: Contraception; HIV; Immune Cells (Mucosal and Systemic); Microbiota

NCT ID: NCT02038335

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Condition: Cervical Cancer; Acquired Immunodeficiency Syndrome

NCT ID: NCT01590017

HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

Condition: HIV-1 Infection

NCT ID: NCT01315353

Brief Intervention for Rural Women at High Risk for HIV/HCV

Condition: Acquired Immune Deficiency Syndrome Virus; Hepatitis C; Drug Abuse

NCT ID: NCT01840722

Vitamin D HIV Study

Condition: HIV

NCT ID: NCT01375010

Situkulwane Lesiphephile-Safe Generations

Condition: HIV/AIDS

NCT ID: NCT01891799

Mother Infant Retention for Health: MIR4Health

Condition: HIV/AIDS

NCT ID: NCT01962220

Vaginal Innate Immunity in Normal and HIV-Infected Women

Condition: HIV; Pregnancy

NCT ID: NCT01318304

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

Condition: HIV Infection; Pregnancy

NCT ID: NCT01621347

Inducing Immune Quiescence to Prevent HIV Infection in Women

Condition: HIV

NCT ID: NCT02079077

Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women

Condition: HIV

NCT ID: NCT01749566

EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

Condition: HIV

NCT ID: NCT01509144

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Condition: HIV Infections; Cachexia

NCT ID: NCT00004400

Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine

Condition: - HIV

NCT ID: NCT01827397

Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women

Condition: HIV Infected Women; Healthy Women Volunteers

NCT ID: NCT01715103

Trial to Improve Access to PMTCT Services and Reduce HIV Transmission From Mother to Child

Condition: Mother-to-child HIV Transmission

NCT ID: NCT01932138

Cambodia Integrated HIV and Drug Prevention Implementation Program

Condition: HIV

NCT ID: NCT01835574

Reducing HIV Stigma for African American Women

Condition: HIV

NCT ID: NCT01893112

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women

Condition: HIV; Contraception

NCT ID: NCT02103660

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Condition: Pregnancy; HIV; AIDS

NCT ID: NCT01667978

Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

Condition: HIV Prevention

NCT ID: NCT01810315

Assessing the Safety of Dapivirine Gel and Film Formulations

Condition: HIV Infections

NCT ID: NCT01548560

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Condition: HIV Infections

NCT ID: NCT00214812

Examining Benefits of HAART Continuation in Postpartum Mothers

Condition: HIV Infections

NCT ID: NCT00955968

Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.

Condition: Depression

NCT ID: NCT02039973

The Health Check-Up for Expectant Moms

Condition: HIV

NCT ID: NCT02120716

Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women

Condition: Cervical Intraepithelial Neoplasia

NCT ID: NCT01723956

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Condition: HIV Infections; Hepatitis B Virus

NCT ID: NCT00404989

Education Program to Promote Female Condom Use

Condition: HIV Infections

NCT ID: NCT00062634

Cryotherapy vs. LEEP to Treat CIN2/3 Among HIV-positive Women

Condition: Cervical Intraepithelial Neoplasia

NCT ID: NCT01298596

Evaluation of Raltegravir During the Third Trimester of Pregnancy

Condition: HIV-1 Infection; PREGNANCY

NCT ID: NCT02099474

Strength Training and Endurance Exercise for LIFE

Condition: HIV

NCT ID: NCT02101060

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

Condition: Hepatitis C Virus; HIV Infections; Pregnancy

NCT ID: NCT00894257

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

Condition: HIV Infections

NCT ID: NCT01828073

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

Condition: HIV Infection

NCT ID: NCT01865786

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

Condition: HIV; Contraception

NCT ID: NCT02082652

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

Condition: HIV

NCT ID: NCT02033109

The ProGirls Study

Condition: Delinquency; HIV Risk; Substance Use; Trauma Exposure

NCT ID: NCT02112201

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

Condition: HIV-1 Infection

NCT ID: NCT01903031

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Condition: Infections, Papillomavirus

NCT ID: NCT01031069

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02075593

WHC+ (Women's Health CoOp PLUS)

Condition: HIV; Sexual Risk; Sexually Transmitted Diseases; Substance Abuse; Violence; Victimization

NCT ID: NCT01497405

Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services

Condition: HIV

NCT ID: NCT01838005

A Risky Sex Prevention Intervention for Minority Middle School Age Girls

Condition: HIV; Risky Sex Prevention

NCT ID: NCT02103218

The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria

Condition: HIV

NCT ID: NCT01936753

Systems Analysis and Improvement to Optimize pMTCT

Condition: HIV

NCT ID: NCT02023658

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Condition: HIV

NCT ID: NCT01691768

Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study

Condition: HIV

NCT ID: NCT01933477

Multicomponent Intervention to Reduce Sexual Risk and Substance Use

Condition: HIV; Sexually Transmitted Infections; Substance Use

NCT ID: NCT01880489

Implementation of an Efficacious Intervention for High Risk Women in Mexico

Condition: HIV; Syphilis; Gonorrhea; Chlamydia

NCT ID: NCT01465607

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

Condition: HIV

NCT ID: NCT01989663

Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring

Condition: HIV

NCT ID: NCT02006264

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

Condition: HIV

NCT ID: NCT00260767

Quantification of Immune Cells in Women Using Contraception (CHIC II)

Condition: HIV; Immune Cells (Mucosal and Systemic); Contraception

NCT ID: NCT01873170

HIV Prevention Intervention for Young Transgender Women

Condition: Sexual Transmission of Infection

NCT ID: NCT01575938

HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence

Condition: Unsafe Sex; Physical Violence; Sexual Assault; Sexual Abuse

NCT ID: NCT01907126

Project N-Liten- HIV Prevention for African American Women

Condition: Sexually Transmitted Diseases

NCT ID: NCT01553682

HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study

Condition: Cervical Cancer

NCT ID: NCT01792973

Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women

Condition: Post Traumatic Stress Disorders; Unsafe Sex; Substance Use Disorders

NCT ID: NCT01849029

A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants

Condition: Healthy Adult Females

NCT ID: NCT02039323

Phase 2a Study of Dapivirine Ring in Adolescent Females

Condition: HIV Prevention

NCT ID: NCT02028338

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV Prevention

NCT ID: NCT01768962

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

Condition: HIV Prevention

NCT ID: NCT01813162

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Condition: NVP Plasma Level; NVP Related Mutation; 3TC Related Mutation

NCT ID: NCT00872872

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Condition: Vaginitis Trichomonal or Due to Trichomonas; Partner Communication

NCT ID: NCT01832480

DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women

Condition: Trichomonas Vaginalis

NCT ID: NCT01874158

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Condition: Cervical High Grade Squamous Intraepithelial Lesion

NCT ID: NCT01928225

Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn

Condition: Infant, Newborn, Diseases; Sepsis; Puerperal Infection

NCT ID: NCT00136370

Expanded Use PK of Dapivirine Vaginal Ring

Condition: Pharmacokinetics

NCT ID: NCT01952561

Evaluation of a Peer Education Program to Promote Family Planning Among Female Sex Workers in Kenya

Condition: Contraception

NCT ID: NCT01957813

Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz

Condition: Drug Interaction

NCT ID: NCT01980342

Long-Acting Reversible Contraception

Condition: Contraception

NCT ID: NCT01299116